November 6, 2009
In the case of a pandemic, and during the seasonal epidemics, once a person has already contracted the influenza, we can do little, other than monitor and treat him with antivirals. However, they are not always a guarantee of success, especially in the case of resistant viruses.
October 21, 2009
Amantadine and rimantadine are the first drugs used against [...]
From adamantine therapeutics failures, interest in developing new drugs against the flu virus had come up. Hence, appeared oseltamivir and zanamivir, neuraminidase inhibitors, the first class of planned drugs against Influenza. Here, the path taken for their production was reverse of that of amantadine. Instead of testing the drug and finding out later how [...]
September 10, 2009
Molecule of the month is an initiative of the RCSB PDB (A Resource for Studying Biological Macromolecules – Protein Data Bank) a protein structure bank. Every month, David Goodsell chooses an interesting structure and describes it, besides illustrating it very well. The illustrations are made available in a high resolution image that may be downloaded.
August 27, 2009
First of all, to start this blog, and discuss the H1N1 and the flu in general, I decided to start with texts considering the other side of the Influenza. Let’s see what is going on with the virus and the decisions taken towards the virus.
With viruses such as Ebola, which killed even 90% of the [...]